Anthony Petrone
Stock Analyst at Mizuho
(4.16)
# 479
Out of 5,090 analysts
201
Total ratings
54.48%
Success rate
12.22%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Outperform | $85 → $100 | $82.95 | +20.55% | 16 | Dec 5, 2025 | |
| AXGN Axogen | Initiates: Outperform | $40 | $33.60 | +19.06% | 1 | Dec 1, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $65 → $70 | $64.01 | +9.36% | 9 | Nov 13, 2025 | |
| ALC Alcon | Maintains: Outperform | $110 → $100 | $81.08 | +23.33% | 11 | Nov 11, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Outperform | $70 → $85 | $70.71 | +20.21% | 8 | Nov 6, 2025 | |
| RMD ResMed | Maintains: Outperform | $310 → $300 | $256.97 | +16.75% | 18 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 → $100 | $86.40 | +15.74% | 10 | Oct 31, 2025 | |
| HOLX Hologic | Downgrades: Neutral | $70 → $78 | $74.86 | +4.20% | 10 | Oct 23, 2025 | |
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $109.25 | -35.93% | 3 | Sep 25, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $83.76 | -16.43% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $70 | $61.65 | +13.54% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $118.86 | +13.58% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $125.38 | +7.67% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $26.69 | -32.56% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $102.03 | -1.98% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $11.63 | +3.18% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $65.69 | +52.23% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $109.81 | +59.37% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $6.89 | +480.55% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $20.57 | -2.77% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $101.15 | -40.68% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $81.91 | -29.19% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $97.85 | +12.42% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $20.13 | -30.45% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $83.00 | +26.51% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $140.03 | +78.53% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.82 | +105.43% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $571.09 | -31.71% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $86.00 | -22.09% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $93.16 | +87.85% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.54 | +116.64% | 3 | May 13, 2020 |
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $82.95
Upside: +20.55%
Axogen
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $33.60
Upside: +19.06%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $64.01
Upside: +9.36%
Alcon
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $81.08
Upside: +23.33%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $70 → $85
Current: $70.71
Upside: +20.21%
ResMed
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $256.97
Upside: +16.75%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $90 → $100
Current: $86.40
Upside: +15.74%
Hologic
Oct 23, 2025
Downgrades: Neutral
Price Target: $70 → $78
Current: $74.86
Upside: +4.20%
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $109.25
Upside: -35.93%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $83.76
Upside: -16.43%
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $61.65
Upside: +13.54%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $118.86
Upside: +13.58%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $125.38
Upside: +7.67%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $26.69
Upside: -32.56%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $102.03
Upside: -1.98%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $11.63
Upside: +3.18%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $65.69
Upside: +52.23%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $109.81
Upside: +59.37%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $6.89
Upside: +480.55%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $20.57
Upside: -2.77%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $101.15
Upside: -40.68%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $81.91
Upside: -29.19%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $97.85
Upside: +12.42%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $20.13
Upside: -30.45%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $83.00
Upside: +26.51%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $140.03
Upside: +78.53%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.82
Upside: +105.43%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $571.09
Upside: -31.71%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $86.00
Upside: -22.09%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $93.16
Upside: +87.85%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.54
Upside: +116.64%